Premium Information is available for this item - Upgrade for $1 a day
6550-01-078-0702
Urine Sugar Test Tablets
6550010780702 010780702 CLINITEST NDC00193-2112-21 2113
January 2023
2
Marketplace 6550-01-078-0702
Request a Quotation from participating marketplace vendors
Related Documents 6550-01-078-0702 5+ Documents (More...)
/fsg-65/fsc-6550/ca
2113 Managed by Canada NSN Created on 6 Jun 1968 Data Last Changed January 2023 NATO Update Count 1
Urine Sugar Test Tablets 6550010780702 day Upgrade your Account Upgrade 6550-01-078-0702Urine Sugar
day Upgrade your Account Upgrade 6550-01-078-0702Urine Sugar Test Tablets6550010780702 010780702 CLINITEST
day Upgrade your Account Upgrade 6550-01-078-0702Urine Sugar Test Tablets6550010780702 010780702 CLINITEST
day Upgrade your Account Upgrade 6550-01-078-0702Urine Sugar Test Tablets6550010780702 010780702 CLINITEST
day Upgrade your Account Upgrade 6550-01-078-0702Urine Sugar Test Tablets6550010780702 010780702 CLINITEST
/fsg-65/fsc-6550/us
Urine Sugar Test Tablets 6550010780702 day Upgrade your Account Upgrade 6550-01-078-0702Urine Sugar
Test Tablets6550010780702 010780702 CLINITEST day Upgrade your Account Upgrade 6550-00-684-8684Urine
/fsg-65/fsc-6550/us
day Upgrade your Account Upgrade 6550-01-132-4952Urine Sugar Test Tablets6550011324952 011324952 CLINITEST
day Upgrade your Account Upgrade 6550-01-078-0702Urine Sugar Test Tablets6550010780702 010780702 CLINITEST
Restrictions 6550-01-078-0702
6550-01-078-0702 is a Urine Sugar Test Tablets that does not have a nuclear hardened feature or any other critical feature such as tolerance, fit restriction or application. Demilitarization of this item has been confirmed and is not currently subject to changes. This item is considered a low risk when released from the control of the Department of Defense. The item may still be subject to the requirements of the Export Administration Regulations (EAR) and the Code of Federal Regulations (CFR). This item may be hazardous as it is in a Federal Supply Class for potentially hazardous items. A MSDS should be available from the supplier for the end user to evaluate any hazards. This item does not contain a precious metal.
Import and Export 6550-01-078-0702
- Schedule B
- Subscribe to View Schedule B
- HTS Code
- Subscribe to View HTS Code
End Users 6550-01-078-0702
- MOE Rule:
- V540
- Effective Date:
- 1 Apr 1991
Approved Sources 6550-01-078-0702
- Part Number
- Manufacturer
- Status
- NDC00193-2112-21
- Manufacturer
- 94371 - Bayer Corp (Active)
- Primary Buy
- Primary Buy
- 2113
- 94371 - Bayer Corp (Active)
- Primary Buy
- Primary Buy
- CLINITEST
- 94371 - Bayer Corp (Active)
- Incomplete Secondary Reference
- Incomplete Secondary Reference
Datasheet 6550-01-078-0702
- Characteristic
- Specifications
- FIIG
- Specifications
- A10000
- Chart Type [BGKW]
- Color
- Usage Design [ALCD]
- For Glucose Test
- Primary Container Type [CQCT]
- Package
- Primary Container Content Quantity [CRLK]
- 2.000 Tablets
NATO Stock Numbers Related to 6550-01-078-0702
Freight Information 6550-01-078-0702
6550-01-078-0702 has freight characteristics.. 6550-01-078-0702 has a variance between NMFC and UFC when transported by rail and the description should be consulted.